Sosei Heptares’ COVID-19 programme advances promising molecules by Lucy Parsons | Nov 20, 2020 | News | 0 R&D programme is focused on developing small molecules against SARS-CoV-2 virus Read More
Sosei Heptares scores $5m milestone payment from Pfizer by Lucy Parsons | Sep 29, 2020 | News | 0 First subject dosed with new drug candidate from strategic collaboration Read More
Sosei Heptares, Takeda embark on strategic R&D partnership by Anna Smith | Aug 5, 2019 | News | 0 The collaboration will combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise. Read More